CluePoints Welcomes Richard Young As New Chief Strategy Officer

CluePoints, a leader in Risk-Based Quality Management (RBQM) solutions, has announced the appointment of Richard Young as its new Chief Strategy Officer. With three decades of expertise in clinical data management, Richard is a recognized authority in the field. He brings valuable experience from his time at Medidata, Cmed Group, and PAREXEL International. 

Most recently, Richard served as Vice President of Strategy for Clinical Data at Veeva Systems. Additionally, he has spent the last three years as the Conference Committee Leader for the SCDM Annual Conference and is currently spearheading their innovations committee. His extensive background will play a crucial role in driving CluePoints' ongoing growth and solidifying its position as the top provider of integrated data review software.

Andy Cooper, CEO at CluePoints, mentioned, “At CluePoints we are committed to innovation and turning data into positive outcomes in clinical trials. Richard has extensive experience of clinical data management and data review, and is a well-regarded expert in his field. His thought leadership is exemplified through his successful podcast series and work on industry forums. Richard sees the journey we are on, our mission to provide the best-in-class integrated data interrogation and risk management platform, and wants to support us on that continued journey.”

He further stated, “Richard will drive the strategy for our product portfolio ensuring the value of our products is aligned with our customers’ needs and we are planning, not just for what is needed this year, but what is needed in five years’ time. He will ensure we remain a leader in RBQM while also establishing ourselves as the market leader for integrated AI-driven SaaS solutions to analyze and interrogate clinical trial data.”

Richard Young said in a statement, “Our industry is living through a digital inflection point, with technology offering us the opportunity to fuel and deliver step changes into global healthcare. Having successfully delivered Veeva Clinical Data, I want to contribute to the next step in realizing the potential for data to reshape and redefine research and development. I believe CluePoints is the perfect place to do that.”